A comparison of the relative merits of radical perineal and radical retropubic prostatectomy

BJU International

Volumn 85, Issue 1, 2000, Pages 95-100

  Sullivan, L D ^a,b   Weir, M J ^a   Kinahan, J F ^a   Taylor, D L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE   (Canada)

Author keywords

Outcome; Perineal; Prostate cancer; Radical prostatectomy; Retropubic

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DRUG USE; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERINEUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; QUALITY OF LIFE; SURGICAL APPROACH;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033956802     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00405.x     Document Type: Article

References (27)

1. 1 Sognani PC, Whitmore WF Jr, Hilaria BS, Batata MA. Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma. Scand J Urol Nephrol Suppl 1980; 55: 205-11
2. 2 Zincke H, Farrow GM, Myers RP, Benson RC Jr, Furlow WL, Utz DC. Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 1982; 128: 498-501
3. 3 Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 492
4. 4 Paulson DF. Radical perineal prostatectomy. Urol Clin N Am 1980; 7: 847
5. 5 Goad JR, Eastham JA, FitzGerald KB et al. Radical retropubic prostatectomy: limited benefit of autologous blood donation. J Urol 1995; 154: 2103-9
6. 6 Donnellan SM, Duncan HJ, MacGregor RJ, Russell JM. Prospective assessment of incontinence after radical retropubic prostatectomy: objective and subjective analysis. Urology 1997; 49: 225-9
7. 7 Rosenzweig KW, Morgan WR, Lytton B, Peschel RE. Prostate specific antigen following radiotherapy for local prostate cancer. J Urol 1995; 153: 1561-4
8. 8 Zagars GK. Prostate specific antigen as an outcome variable to T1 and T2 prostate cancer treated by radiation therapy. J Urol 1994; 152: 1786-91
9. 9 Zietman AL, Coen JJ, Shipley WU, Willet CG, Efird JT. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. J Urol 1994; 151: 640-5
10. 10 Steiner MS, Marshall FF. Mini-laparotomy staging pelvic lymphadenectomy (minilap): alternative to standard and laparoscopic pelvic lymphadenectomy. Urology 1993; 41: 201-6
11. 11 Schuessler WW, Pharand D, Vancaillie TG. Laparoscopic standard pelvic node dissection for carcinoma of the prostate: is it accurate? J Urol 1993; 150: 898-901
12. 12 Sullivan LD, Rabbani F. Should we reconsider the indications for ileo-obturator node dissection with localized prostate cancer? Br J Urol 1995; 75: 33-7
13. 13 Narayan P, Fournier G, Gajendran V et al. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 1994; 44: 519-24
14. 14 Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994; 151: 1315-20
15. 15 Weldon VE, Tavel FR, Neuwirth H, Cohen R. Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. J Urol 1995; 153: 1565-9
16. 16 Parra RO, Boullier JA, Rauscher JA, Cummings JM. The value of laparoscopic lymphadenectomy in conjunction with radical perineal or retropubic prostatectomy. J Urol 1994; 151: 1599-602
17. 17 Goldenberg SL, Klotz LH, Srigley J et al. Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. J Urol 1996; 56: 873-7
18. 18 Gleave ME, Goldenberg SL, Jones EC, Brushovsky N, Sullivan LD. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 1996; 55: 213-9
19. 19 Litwin M, Hays RD, Fink A et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35
20. 20 Walsh PC, Lepor H, Eggleston JD. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473
21. 21 Belt E. Radical perineal prostatectomy in early carcinoma of the prostate. J Urol 1942; 48: 287
22. 22 Sullivan LD, Kinahan JF, Leone EF. Radical perineal prostatectomy: a simplified approach. Can J Urol 1997; 4: 386-91
23. 23 Doublet JD, Lagrange L, Ciofu C, Thibault P, Gattegno B. Radical prostatectomy: comparison of the perineal and retropubic route (40 patients). Preliminary results. Prog Urol 1994; 4: 33-9
24. 24 Paulson DF. The impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994; 152: 1826-30
25. 25 Catalona WJ, Smith DS. 5 year tumor response rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994; 152: 1837-42
26. 26 Frazier HA, Robertson JE, Paulson DF. Radical prostatectomy: the pros and cons of the perineal versus retropubic approach. J Urol 1992; 147: 888-90
27. 27 Haab F, Boccon-Gibod L, Delmas V, Boccon-Gibod L, Toublanc M. Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer. Br J Urol 1994; 74: 626-9